0001127602-18-001261.txt : 20180105
0001127602-18-001261.hdr.sgml : 20180105
20180105162523
ACCESSION NUMBER: 0001127602-18-001261
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180104
FILED AS OF DATE: 20180105
DATE AS OF CHANGE: 20180105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAHON PAUL A
CENTRAL INDEX KEY: 0001231589
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 18513688
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-01-04
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001231589
MAHON PAUL A
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
EVP & General Counsel
Common Stock
2018-01-04
4
M
0
6000
94.96
A
41426
D
Common Stock
2018-01-04
4
D
0
6000
149.83
D
35426
D
Share Tracking Award
94.96
2018-01-04
4
M
0
6000
0
D
2015-03-14
2024-03-14
Common Stock
6000
119000
D
This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
/s/ John S. Hess, Jr. under Power of Attorney
2018-01-05